作者：
Van Cutsem, E. [1]
;
Yoshino, T. [2]
;
Lenz, H. J. [3]
;
Lonardi, S. [4]
;
Falcone, A. [5]
;
Limon, M. L. [6]
;
Saunders, M. [7]
;
Sobrero, A. [8]
;
Park, Y. S. [9]
;
Ferreiro, R. [10]
;
Hong, Y. S. [11]
;
Tomasek, J. [12]
;
Taniguchi, H. [13]
;
Ciardiello, F. [14]
;
Stoehr, J. [15]
;
Oum'Hamed, Z. [16]
;
Vlassak, S. [17]
;
Studeny, M. [18]
;
Argiles, G. [19]
作者单位：
SCS Boehringer Ingelheim CommV, Brussels, Belgium
[1]
Boehringer Ingelheim GmbH & Co KG, Pharma GmbH & Co KG, Biberach, Germany
[2]
Masaryk Mem Canc Inst, Dept Complex Oncol Care, Brno, Czech Republic
[3]
Ramon & Cajal Hosp, Dept Clin Oncol, Madrid, Spain
[4]
Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[5]
Asan Med Ctr, Dept Oncol, Seoul, South Korea
[6]
Boehringer Ingelheim France SAS, Reims, France
[7]
Ist Oncol Veneto IRCCS, Dept Clin & Expt Oncol, Med Oncol Unit 1, Padua, Italy
[8]
Univ Hosp Gasthuisberg Leuven, Div Digest Oncol, Leuven, Belgium
[9]
Samsung Med Ctr, Dept Hematol & Oncol, Seoul, South Korea
[10]
Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
[11]
Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy
[12]
Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
[13]
Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Chiba, Japan
[14]
Seconda Univ Napoli, Oncol Med, Naples, Italy
[15]
Boehringer Ingelheim GmbH & Co KG, Div Med, Clin Dev Dept, Vienna, Austria
[16]
Azienda Osped San Martino, Dept Med Oncol, Genoa, Italy
[17]
Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England
[18]
Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA USA
[19]
发布时间
2019-03-17
换一批
